HOME >> MEDICINE >> NEWS
90 high schools will participate in UNC-CH head injury study

CHAPEL HILL - Among the scariest injuries in football and other sports, blows to the head can mean nothing more than a little short-lasting pain or forever change an athlete's life for the worse. For that reason, doctors, athletic trainers and coaches face a daunting task when deciding which injuries to take most seriously.

Now, University of North Carolina at Chapel Hill researchers who are trying to make sports safer soon may be able to take some of the guesswork out of how to handle head trauma. They have received two grants totaling $531,000 to support a two-year investigation of such injuries in games and practices.

The grants will come from the U.S. Centers for Disease Control and Prevention and the National Operating Committee on Standards for Athletic Equipment to fund a project involving 90 high schools in seven East Coast states and the District of Columbia. The seven are Delaware, Maryland, New Jersey, North Carolina, Pennsylvania, South Carolina and Virginia.

"Right now we're recruiting certified athletic trainers at all the schools," said Dr. Kevin M. Guskiewicz, assistant professor of exercise and sport science at UNC-CH and study leader. "In February, we'll begin training the athletic trainers at the various study sites on how to assess concussions using several objective measures, some of which have been developed by members of our research team."

"Some of the assessments involve tests of thinking ability, memory and concentration," Guskiewicz said. "Others involve tests of how well athletes maintain their posture and balance while standing on one foot on a device called a balance box that moves beneath them. During testing, the goal is to keep their bodies and the box as motionless as possible."

All athletes on three of each school's teams will be tested before their season begins and then again immediately after suffering a concussion during any practice or game. Tests will be given again three, 24, 48 and 72 hours aft
'"/>

Contact: David Williamson
David_Williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
2-Dec-1999


Page: 1 2 3

Related medicine news :

1. New research calls for schools to be more aware of head injuries
2. Tackling medical schools informal curriculum
3. New asthma program in Detroit public schools may improve student grades and decrease absences
4. Asthma symptoms reduced among children whose schools provided asthma medication
5. Random drug testing in schools is unworkable
6. UNC study reveals few problems banning smoking at NC schools
7. Bullying in schools pervasive, UCLA study finds
8. Tobacco use common in schools demonstrating poor academic performance
9. Poorer performing Philadelphia schools have more undiagnosed asthma, Jefferson study finds
10. New tools help families and schools prepare for disasters
11. Elementary schools need a lesson in bathroom breaks

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: high schools will participate UNC head injury study

(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: